U3-1565

· Daiichi Sankyo

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for U3-1565, covering 2014-05-19 to 2014-05-19. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors [Phase 1]